Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06793683
EARLY_PHASE1

Early BOTOX After Spinal Cord Injury

Sponsor: University of Washington

View on ClinicalTrials.gov

Summary

The investigators would like to improve our understanding of how early intervention with the use of bladder chemodenervation can preserve bladder function in those with a new SCI. Although detrimental cystometric and tissue changes are known to occur, often within 3 months after SCI, the investigators seek to document the time course of these changes and the range of severity of those changes in both those participants that receive prophylactic treatment and those who do not.

Official title: Early Detrusor Chemodenervation to Preserve Bladder Compliance and Longevity After Spinal Cord Injury

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2024-07-27

Completion Date

2028-09-30

Last Updated

2025-01-27

Healthy Volunteers

No

Interventions

DRUG

Bladder chemodenervation (Botox)

BoNT-A (Botox) 200 U will be injected into the detrusor (bladder wall muscle).

PROCEDURE

Bladder Sham (Saline) Injection Procedure

20mL placebo (saline only), will be injected into the detrusor (bladder wall muscle).

Locations (1)

Harborview Medical Center

Seattle, Washington, United States